Regeneron Pharmaceuticals Inc (REGN) — Technical state

As of 2026-11-09 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

Closelooknet score: 64 out of 100 (momentum 84 · quality 72 · valuation 45), as of 2026-11-11.
Signal: Trending — Above its 20-, 50- and 200-day — still in an uptrend. (as of 2026-11-09)
Trend: Regeneron Pharmaceuticals Inc trades 14.0% above its 50-day and 23.8% above its 200-day moving average. (as of 2026-11-09)
Index seat: HALO Growth 100

Regeneron discovers, develops, manufactures and sells medicines across eye disease, immune and inflammatory conditions, cardiovascular and metabolic disorders, neurological and infectious disease, rare disease, cancer and blood disorders. Its marketed products include an eye injection for macular degeneration and related retinal conditions, an injection for atopic dermatitis and asthma, a skin-cancer treatment, a cholesterol-lowering injection and a rheumatoid arthritis treatment.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the REGN overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Trending

Above its 20-, 50- and 200-day — still in an uptrend.

The moving-average stack

vs 20-day+8.8%
vs 50-day+14%
vs 200-day+23.8%
52-week band7.2% off the high · +70.5% off the low
Streak2 consecutive up sessions
Stochastic%K 59.3 · %D 65.7

Continue: the REGN chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-11-09

Quick answers

What is the current Closelooknet signal on REGN?

Trending — Above its 20-, 50- and 200-day — still in an uptrend. As of 2026-11-09; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is REGN above its 50-day and 200-day moving averages?

As of 2026-11-09, Regeneron Pharmaceuticals Inc trades +14% above its 50-day and +23.8% above its 200-day average, with the 20-day +8.8% away.

How far is REGN from its 52-week high?

7.2% below the 52-week high and 70.5% above the 52-week low, as of 2026-11-09.

Mentioned on Closelooknet

Where REGN appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000Midday 10 · 21 Aug 2026Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG…

Related in the Closelooknet universe

same Closelooknet index seat first, then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.